de Oliveira Rezende, A.; Sabóia, R.S.; da Costa, A.C.; da Silva Monteiro, D.M.P.; Zagmignan, A.; Santiago, L.Â.M.; Carvalho, R.C.; Pereira, P.V.S.; Junqueira-Kipnis, A.P.; de Sousa, E.M.
Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade. Biomedicines 2022, 10, 817.
https://doi.org/10.3390/biomedicines10040817
AMA Style
de Oliveira Rezende A, Sabóia RS, da Costa AC, da Silva Monteiro DMP, Zagmignan A, Santiago LÂM, Carvalho RC, Pereira PVS, Junqueira-Kipnis AP, de Sousa EM.
Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade. Biomedicines. 2022; 10(4):817.
https://doi.org/10.3390/biomedicines10040817
Chicago/Turabian Style
de Oliveira Rezende, Aline, Rafaella Santos Sabóia, Adeliane Castro da Costa, Diana Messala Pinheiro da Silva Monteiro, Adrielle Zagmignan, Luis Ângelo Macedo Santiago, Rafael Cardoso Carvalho, Paulo Vitor Soeiro Pereira, Ana Paula Junqueira-Kipnis, and Eduardo Martins de Sousa.
2022. "Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade" Biomedicines 10, no. 4: 817.
https://doi.org/10.3390/biomedicines10040817
APA Style
de Oliveira Rezende, A., Sabóia, R. S., da Costa, A. C., da Silva Monteiro, D. M. P., Zagmignan, A., Santiago, L. Â. M., Carvalho, R. C., Pereira, P. V. S., Junqueira-Kipnis, A. P., & de Sousa, E. M.
(2022). Restricted Activation of the NF-κB Pathway in Individuals with Latent Tuberculosis Infection after HIF-1α Blockade. Biomedicines, 10(4), 817.
https://doi.org/10.3390/biomedicines10040817